{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T03:51:18Z","timestamp":1769140278960,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ijpharm.2017.02.024","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T12:18:35Z","timestamp":1487074715000},"page":"196-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["In situ hybrid nano drug delivery system (IHN-DDS) of antiretroviral drug for simultaneous targeting to multiple viral reservoirs: An in vivo proof of concept"],"prefix":"10.1016","volume":"521","author":[{"given":"Anil B.","family":"Jindal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagar S.","family":"Bachhav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padma V.","family":"Devarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2017.02.024_bib0005","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1208\/s12249-009-9197-2","article-title":"Diazepam-loaded solid lipid nanoparticles: design and characterization","volume":"10","author":"Abdelbary","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.molliq.2011.01.015","article-title":"Effect of N,N-dimethyl acetamide on the critical micelle concentration of aqueous solutions of sodium surfactants","volume":"160","author":"Alawi","year":"2011","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0015","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1517\/17425247.2013.781999","article-title":"Advances in brain targeting and drug delivery of anti-HIV therapeutic agents","volume":"10","author":"Al-Ghananeem","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0020","first-page":"981","article-title":"Design and development of nevirapine loaded surfactant free chitosan microemulsion","volume":"68","author":"Bajaj","year":"2011","journal-title":"Acta Pol. Pharm. Drug Res."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.02.024_bib0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.18433\/J3D59T","article-title":"Kinetic analysis of drug release from nanoparticles","volume":"11","author":"Barzegar-Jalali","year":"2008","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0030","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ijpharm.2012.07.070","article-title":"Chemico-physical investigation of tenofovir loaded polymeric nanoparticles","volume":"436","author":"Belletti","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0035","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijpharm.2011.11.035","article-title":"Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability","volume":"423","author":"Benival","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0040","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nano.2011.01.017","article-title":"Synergistic encapsulation of the anti-HIV agent efavirenz within mixed poloxamine\/poloxamer polymeric micelles","volume":"7","author":"Chiappetta","year":"2011","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0045","doi-asserted-by":"crossref","first-page":"e113558","DOI":"10.1371\/journal.pone.0113558","article-title":"Effect of formulation variables on preparation of celecoxib loaded polylactide-co-glycolide nanoparticles","volume":"9","author":"Cooper","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0050","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.2174\/0929867311209025052","article-title":"In vitro studies of water-stable cationic carbosilane dendrimers as delivery vehicles for gene therapy against HIV and hepatocarcinoma","volume":"19","author":"de las Cuevas","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0055","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00126334-200406010-00001","article-title":"Transport of HIV protease inhibitors through the blood\u2013brain barrier and interactions with the efflux proteins, P-glycoprotein and multidrug resistance proteins","volume":"36","author":"Gimenez","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0060","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.addr.2009.11.018","article-title":"Non-polymeric nano-carriers in HIV\/AIDS drug delivery and targeting","volume":"62","author":"Gupta","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijpharm.2007.12.028","article-title":"Effect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism","volume":"356","author":"Huang","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0070","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.med.53.082901.104024","article-title":"The challenge of viral reservoirs in HIV-1 infection","volume":"53","author":"Blankson","year":"2003","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0075","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2012.02.042","article-title":"Self nanoprecipitating preconcentrate of tamoxifen citrate for enhanced bioavailability","volume":"429","author":"Kapse","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0080","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1002\/jps.22711","article-title":"Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers","volume":"100","author":"Kasongo","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0085","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1016\/j.biomaterials.2013.03.094","article-title":"The effect of liposomal size on the targeted delivery of doxorubicin to Integrin \u03b1v\u03b23-expressing tumor endothelial cells","volume":"34","author":"Kibria","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-5173(00)00568-8","article-title":"Myotoxicity studies of injectable biodegradable in-situ forming drug delivery systems","volume":"212","author":"Kranz","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0095","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1359-6446(00)01632-9","article-title":"Efflux transport systems for drugs at the blood\u2013brain barrier and blood-cerebrospinal fluid barrier (Part 1)","volume":"6","author":"Kusuhara","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijbiomac.2006.03.006","article-title":"Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine","volume":"38","author":"Li","year":"2006","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0105","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/10717544.2013.838014","article-title":"Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting","volume":"21","author":"Mahajan","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0110","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1021\/la00081a041","article-title":"Determination of critical micelle concentration of surfactants and the partition coefficient of an electrochemical probe by using cyclic voltammetry","volume":"4","author":"Mandal","year":"1988","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrmicro.2015.5","article-title":"HIV reservoirs: what, where and how to target them","volume":"14","author":"Churchill","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2014.09.031","article-title":"Novel nelfinavir mesylate loaded d-\u03b1-tocopheryl polyethylene glycol 1000 succinate micelles for enhanced pediatric anti HIV therapy: in vitro characterization and in vivo evaluation","author":"Moretton","year":"2014","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0125","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4103\/0250-474X.45401","article-title":"Solid-state characterization of nevirapine","volume":"70","author":"Panchagnula","year":"2008","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0130","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1208\/s12249-011-9636-8","article-title":"Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel","volume":"12","author":"Pandita","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0135","first-page":"301","article-title":"Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique","volume":"64","author":"Pandita","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1086\/338256","article-title":"Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication","volume":"34","author":"Pomerantz","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0145","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.nano.2013.05.003","article-title":"Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections","volume":"9","author":"Puligujja","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0150","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijpharm.2012.04.054","article-title":"Investigation on the stability of saquinavir loaded liposomes: implication on stealth, release characteristics and cytotoxicity","volume":"431","author":"Ramana","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0155","first-page":"3","article-title":"Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy","volume":"5","author":"Saksena","year":"2003","journal-title":"AIDS Rev."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0160","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2174\/156720112802650707","article-title":"Comparative studies of lamivudine\u2013zidovudine nanoparticles for the selective uptake by macrophages","volume":"9","author":"Sankar","year":"2012","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0165","first-page":"195727","article-title":"Drug solubility: importance and enhancement techniques","volume":"2012","author":"Savjani","year":"2012","journal-title":"ISRN Pharm."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0170","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jama.280.1.67","article-title":"Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy","volume":"280","author":"Schrager","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0175","first-page":"1","article-title":"Ciprofloxacin controlled-solid lipid nanoparticles: characterization, in vitro release, and antibacterial activity assessment","volume":"2017","author":"Shazly","year":"2017","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0180","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijpharm.2011.09.041","article-title":"Surface modified nevirapine nanosuspensions for viral reservoir targeting: in vitro and in vivo evaluation","volume":"421","author":"Shegokar","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0185","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0168-3659(94)00097-E","article-title":"Physico-chemical characterization of a polymeric injectable implant delivery system","volume":"33","author":"Shively","year":"1995","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0190","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/aic.690050421","article-title":"Interfacial turbulence: Hydrodynamic instability and the marangoni effect","volume":"5","author":"Sterling","year":"1959","journal-title":"AIChE"},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0195","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing excipients in oral and injectable formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0200","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1517\/17425247.3.5.613","article-title":"Nanoparticulate drug carriers for delivery of HIV\/AIDS therapy to viral reservoir sites","volume":"3","author":"Vyas","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0205","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2007.06.016","article-title":"Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations","volume":"347","author":"Vyas","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0210","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijpharm.2012.03.027","article-title":"Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies","volume":"430","author":"Wang","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0215","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1023\/A:1018888927852","article-title":"Body distribution of camptothecin solid lipid nanoparticles after oral administration","volume":"16","author":"Yang","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.02.024_bib0220","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/08982104.2013.810645","article-title":"Formulation and transport properties of tenofovir loaded liposomes through Caco-2 cell model","volume":"23","author":"Zidan","year":"2013","journal-title":"J. Liposome Res."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317301059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317301059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T01:54:56Z","timestamp":1538013296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317301059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":44,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0378517317301059"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.02.024","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ hybrid nano drug delivery system (IHN-DDS) of antiretroviral drug for simultaneous targeting to multiple viral reservoirs: An in vivo proof of concept","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}